Product Information
REFRESH CELLUVISC 1% EYE GEL is a brand product labeled by Allergan, Inc., priced at $0.3665 per EA under NDC 00023455430. Its NADAC has been published 515 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the carboxymethylcellulose sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
Allergan, Inc.NDC
00023455430
Classification
Brand
Dosage Form
GEL
Route
OPHTHALMIC
Effective Date
5/20/2026
Active Ingredients
CARBOXYMETHYLCELLULOSE SODIUMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
10/4/1989
Price Statistics
The NADAC for REFRESH CELLUVISC 1% EYE GEL has been published 515 times since Nov 28, 2013, and over the history we have for it it has risen 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3665 per EA |
|---|---|
| All-time high | $0.3666 (Jan 14, 2026) |
| All-time low | $0.3020 (Jan 22, 2014) |
| 52-week high | $0.3666 |
| 52-week low | $0.3643 |
| Median price | $0.3254 |
| Average price | $0.3310 |
| Largest weekly change | +12.3% (Jun 19, 2024) |
| Weeks tracked | 515 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the carboxymethylcellulose sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
carboxymethylcellulose sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REFRESH CELLUVISC 1% EYE GEL?
The current National Average Drug Acquisition Cost (NADAC) for REFRESH CELLUVISC 1% EYE GEL, manufactured by Allergan, Inc., is $0.3665 per EA (NDC 00023455430), effective Sep 30, 2026.
How has the price of REFRESH CELLUVISC 1% EYE GEL changed over time?
Over the history we have for it, the NADAC for REFRESH CELLUVISC 1% EYE GEL has risen 17.5%. It has been tracked across 515 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for REFRESH CELLUVISC 1% EYE GEL?
Since Nov 28, 2013, the NADAC for REFRESH CELLUVISC 1% EYE GEL has ranged from a low of $0.3020 (Jan 22, 2014) to a high of $0.3666 (Jan 14, 2026), with a median of $0.3254 per EA.
Are there cheaper alternatives to REFRESH CELLUVISC 1% EYE GEL?
No other NADAC-published product currently shares the active ingredient and strength of REFRESH CELLUVISC 1% EYE GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REFRESH CELLUVISC 1% EYE GEL?
REFRESH CELLUVISC 1% EYE GEL (NDC 00023455430) is labeled by Allergan, Inc., and CMS classifies it as a brand product.